Ticker Scorecard - VINC Basics Company: Vincerx Pharma, Inc. Common Stock IPO Date: May 5, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.78M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.39% Avg Daily Range (30 D): $0.06 | 5.68% Avg Daily Range (90 D): $0.03 | 5.09% Institutional Daily Volume Avg Daily Volume: .04M Avg Daily Volume (30 D): .65M Avg Daily Volume (90 D): .4M Trade Size Avg Trade Size (Sh.): 33 Avg Trade Size (Sh.) (30 D): 137 Avg Trade Size (Sh.) (90 D): 86 Institutional Trades Total Inst.Trades: 48 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $.98M Avg Inst. Trade (90 D): $.98M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.86M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 16.22K     News Jan 10, 2025 @ 2:55 PM SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ... Source: N/A Jan 10, 2025 @ 2:37 PM Kuehn Law Encourages VINC, NEUE, GETY, and CLBR In... Source: Globe Newswire Jan 2, 2025 @ 10:30 PM $HAREHOLDER ALERT: The M&A Class Action Firm Is In... Source: Globe Newswire Jun 27, 2024 @ 4:00 PM Vincerx Pharma (VINC) Moves to Buy: Rationale Behi... Source: Zacks Equity Research May 14, 2024 @ 8:15 PM Vincerx Pharma Reports First Quarter 2024 Financia... Source: Vincerx Pharma, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.88 $-.17 $-.05 Diluted EPS $-.88 $-.17 $-.05 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -27.03M $ -7.84M $ -1.81M Operating Income / Loss $ -28.17M $ -7.79M $ -7.37M Cost of Revenue $ $ $ Net Cash Flow $ -12.12M $ -4.98M $ -4.78M PE Ratio     Splits Jan 28, 2025:   20:1